Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | FLT3 | P36888 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12927505 | 0.91 | CYP1A2 (0.48) | MTNR1ACYP2A6CYP1A2HTR2ACYP11B1 | |
| SCHEMBL12589223 | 0.91 | ACHE (0.48) | ACHEMTNR1ATDP1KDM4EALDH1A1 | |
| SCHEMBL12646378 | 0.86 | MAPT (0.46) | ACHEMTNR1ACYP2A6CYP1A2TDP1 | |
| SCHEMBL12589226 | 0.82 | ACHE (0.40) | ACHETDP1KDM4EALDH1A1MAPT | |
| SCHEMBL17552367 | 0.79 | ACHE (0.52) | ACHECYP2A6CYP1A2TDP1KDM4E | |
| SCHEMBL10023273 | 0.79 | ACHE (0.52) | ACHECYP2A6CYP1A2TDP1KDM4E | |
| SCHEMBL17552365 | 0.79 | ACHE (0.52) | ACHECYP2A6CYP1A2TDP1KDM4E | |
| SCHEMBL16108132 | 0.77 | MAPT (0.52) | ACHEMTNR1ACYP2A6CYP1A2TDP1 | |
| SCHEMBL8840938 | 0.77 | ACHE (0.54) | ACHEKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL12646381 | 0.76 | MAPT (0.41) | ACHEMTNR1ATDP1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586207-B2 | Fused polycyclic compound and organic light emitting device having the compound | CANON KABUSHIKI KAISHA (JP) | 2013-11-19 | — | — | US | disclosed |
| US-20110024737-A1 | FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2011-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110024737-A1 | FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | MAP1LC3C, MAP1LC3A, MAP1LC3B | ACHE 1252/4885MTNR1A 3505/4885CYP2A6 2219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.